Basal Insulins - Pharmacodynamics

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

May 31, 2005

Conditions
Diabetes
Interventions
DRUG

Insulin detemir

0.4 U/kg bw insulin detemir injected s.c. in the thigh.

DRUG

Insulin glargine

0.4 U/kg bw insulin glargine injected s.c. in the thigh

DRUG

Insulatard

0.4 U/kg bw NPH insulin injected s.c. in the thigh

Trial Locations (1)

8000

Medical department M (Endocrinology and Diabetes), Aarhus University Hospital, Aarhus

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Danish Diabetes Association

OTHER

collaborator

The Institute of Experimental Clinical Research, University of Aarhus

UNKNOWN

collaborator

Novo Nordisk A/S

INDUSTRY

lead

University of Aarhus

OTHER